Diabetes
-
19Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015–2018. Diabetes Care 2020;43:244–246
We appreciate Dr. Brand’s commentary (1) on our brief report (2) and substantively agree with her points about the role of “duplication...
-
21Diabetes Care Platform Adds New Remote Tool
Diabetes Care Platform Adds New Remote Tool The pharma company Roche is adding a new remote-patient-monitoring tool to its Diabetes Care Platform....
-
34
The Effect of a Novel Low-Volume Aerobic Exercise Intervention on Liver Fat in Type 2 Diabetes: A Randomized Controlled Trial
The Effect of a Novel Low-Volume Aerobic Exercise Intervention on Liver Fat in Type 2 Diabetes: A Randomized Controlled Trial Angelo Sabag,...
-
19
Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015–2018. Diabetes Care 2020;43:244–246
Flory et al. (1) analyzed cases of lactic acidosis (LA) reported to the U.S. Food and Drug Administration’s Adverse Event Reporting System...
-
23
Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials
Incidence of Hospitalization for Heart Failure Relative to Major Atherosclerotic Events in Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials Julian...
-
20
Response to Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912
We thank Wu et al. (1) for their correspondence. We agree, low levels of high-sensitivity C-reactive protein (hs-CRP) are characteristic of heterozygous...
-
34
Impaired Succinate Response to a Mixed Meal in Obesity and Type 2 Diabetes Is Normalized After Metabolic Surgery
AbstractOBJECTIVE To explore the meal response of circulating succinate in patients with obesity and type 2 diabetes undergoing bariatric surgery and to...
-
25The Sugar Science – Diabetes Daily
This content originally appeared on Beyond Type 1. Republished with permission.By Monica WestleyAs a scientist and a parent of a child with...
-
19Attaining functional levels of visual acuity after vitrectomy for retinal detachment secondary to proliferative diabetic retinopathy
1.Bourne, R. R. et al. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob. Health. 1, 339–349 (2013).Article Google Scholar ...
-
20
Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912
With great interest, we have read the article by Misra et al. (1), which reported a family that suffered from young-onset and...
-
29
Bone Mass and Density in Youth With Type 2 Diabetes, Obesity, and Healthy Weight
Bone Mass and Density in Youth With Type 2 Diabetes, Obesity, and Healthy Weight Joseph M. Kindler, Andrea Kelly, Philip R. Khoury,...
-
35
Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study
Several oral hypoglycemic agents (OHA) are not recommended for patients with advanced chronic kidney disease (CKD). Early use of supplemental insulin, which...
-
29
Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
AbstractOBJECTIVE The principle of replacing prandial insulin lispro with a once-weekly glucagon-like peptide 1 receptor agonist (GLP-1RA) for type 2 diabetes inadequately...
